LifeTech Scientific Corporation (HKG:1302)
Hong Kong · Delayed Price · Currency is HKD 1.470
+0.070 (5.00%)
Jul 31, 2026, 4:08 PM HKT
LifeTech Scientific Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,809 | 7,225 | 6,437 | 10,881 | 11,945 | 16,946 | |
Market Cap Growth | -30.66% | 12.26% | -40.85% | -8.91% | -29.51% | -17.70% |
Enterprise Value | 5,496 | 5,665 | 5,395 | 9,846 | 10,333 | 15,560 |
Last Close Price | 1.47 | 1.56 | 1.39 | 2.35 | 2.58 | 3.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 40.03 | 43.92 | 27.20 | 37.52 | 32.48 | 47.20 |
Forward PE | - | 14.38 | 15.37 | 22.45 | 20.85 | 31.39 |
PS Ratio | 4.47 | 4.74 | 4.64 | 7.79 | 9.63 | 14.92 |
PB Ratio | 1.76 | 1.87 | 1.74 | 2.97 | 3.62 | 5.46 |
P/TBV Ratio | 1.84 | 1.95 | 1.77 | 3.00 | 3.75 | 5.69 |
P/FCF Ratio | 12.73 | 13.50 | 48.46 | 45.47 | 65.25 | 83.53 |
P/OCF Ratio | 11.14 | 11.82 | 18.82 | 23.63 | 27.21 | 31.30 |
PEG Ratio | - | 1.14 | 1.14 | 1.14 | 1.14 | 1.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.61 | 3.72 | 3.89 | 7.05 | 8.33 | 13.70 |
EV/EBITDA Ratio | 16.27 | 17.45 | 17.57 | 22.80 | 21.66 | 30.59 |
EV/EBIT Ratio | 24.50 | 26.05 | 24.18 | 27.21 | 24.76 | 34.66 |
EV/FCF Ratio | 10.27 | 10.59 | 40.62 | 41.15 | 56.44 | 76.70 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.04 |
Debt / FCF Ratio | 0.02 | 0.02 | 0.04 | 0.04 | 0.06 | 0.10 |
Net Debt / Equity Ratio | -0.33 | -0.33 | -0.34 | -0.35 | -0.28 | -0.58 |
Net Debt / EBITDA Ratio | -3.91 | -3.91 | -4.08 | -2.98 | -1.95 | -3.52 |
Net Debt / FCF Ratio | -2.37 | -2.37 | -9.43 | -5.39 | -5.09 | -8.84 |
Asset Turnover | 0.28 | 0.28 | 0.27 | 0.30 | 0.32 | 0.30 |
Inventory Turnover | 0.72 | 0.72 | 0.63 | 0.75 | 1.21 | 1.55 |
Quick Ratio | 1.19 | 1.19 | 1.73 | 1.77 | 1.80 | 3.40 |
Current Ratio | 1.57 | 1.57 | 2.86 | 2.90 | 2.39 | 3.81 |
Return on Equity (ROE) | 3.23% | 3.23% | 4.96% | 3.44% | 11.69% | 11.59% |
Return on Assets (ROA) | 2.46% | 2.46% | 2.73% | 4.90% | 6.71% | 7.45% |
Return on Invested Capital (ROIC) | 4.92% | 4.95% | 7.98% | 9.46% | 19.66% | 25.20% |
Return on Capital Employed (ROCE) | 5.50% | 5.50% | 5.10% | 8.40% | 11.90% | 13.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.42% | 2.28% | 3.68% | 2.67% | 3.08% | 2.12% |
FCF Yield | 7.86% | 7.41% | 2.06% | 2.20% | 1.53% | 1.20% |
Buyback Yield / Dilution | -0.54% | -0.54% | 1.16% | -0.92% | 3.45% | -3.95% |